title: Ebola virus disease: roles and considerations for pharmacists.
abstract: Ebola virus disease (EVD) poses significant clinical care implications for pharmacists. Emergency preparedness efforts should be undertaken to ensure vital response to EVD. Pharmacists should consider factors such as enhanced use of resources for front-line EVD patient care along with procurement of investigational medications. Appropriate and timely preparation, distribution, and administration of treatment for patients with EVD in the setting of substantial critical illness as well as infection control measures are essential. Aggressive supportive care and early, goal-directed therapy are cornerstones of therapy, whereas investigational treatments for EVD will likely play a larger, more well-defined role as future clinical trials are conducted.
authors.affiliation: Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA, USA guarascioa@duq.edu.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Guarascio
authors.affiliation: Texas Health Presbyterian Hospital, Dallas, TX, USA.
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Faust
authors.affiliation: Texas Health Presbyterian Hospital, Dallas, TX, USA.
authors.forename: Lyndsay
authors.initials: L
authors.lastname: Sheperd
authors.affiliation: Mylan School of Pharmacy at Duquesne University, Pittsburgh, PA, USA.
authors.forename: Lauren A
authors.initials: LA
authors.lastname: O'Donnell
mesh_terms: D016638:Critical Illness; D019142:Hemorrhagic Fever, Ebola / Q000628:therapy*; D006801:Humans; D017053:Infection Control; D010595:Pharmacists; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*
keywords: antivirals; critical care; infectious diseases; personnel management; pharmaceutical care; sepsis; viral infections